From the Publisher
A welcome letter from ACT's Publisher Wayne Blow
Dear Colleague,
Welcome to the Applied Clinical Trials' Directory & Buyers' Guide for 2006. Enclosed within these pages is a comprehensive list of key leaders and resources in the clinical trials industry. We know you will find a great deal of information to facilitate your search for suppliers and outsourcers of Clinical Packaging, Consulting, CROs, Contract Research Services, Information Technology, IRBs, Laboratories and Laboratory Supplies, Subject Recruitment, and Training and Education within the industry.
Wayne K. Blow
The clinical trials community is continually growing, and it is important to keep up with the changing environment. The purpose of this directory and buyers' guide is to keep you abreast of the changes taking place, whether they are in clinical trials monitoring, specialty labs, EDC suppliers, software developers or training and education. Clinical trials require strategic partners and outsourcers who will provide solutions to challenges, and they can be easily accessed within these pages.
Whether you are looking for a particular company or researching CROs, you will find what you need quickly in the ACT Directory & Buyers' Guide. While clinical trials colleagues communicate with you via the Internet, direct mail or at workshops and conferences, this single-source, desktop print directory will have distinct advantages. The directory is set up with a comprehensive category list and an alphabetized index. The directory also includes a section on professional societies and associations and a calendar of clinical trials events.
I hope our ACT 2006 Directory & Buyers' Guide proves to be an essential part of your desktop reference tools.
Best regards,
Wayne K. Blow
Publisher, Applied Clinical Trials
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
